ID   WECB_ECOLI              Reviewed;         376 AA.
AC   P27828; P76753; Q2M894;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 2.
DT   15-MAR-2017, entry version 139.
DE   RecName: Full=UDP-N-acetylglucosamine 2-epimerase {ECO:0000255|HAMAP-Rule:MF_02028, ECO:0000305};
DE            EC=5.1.3.14 {ECO:0000255|HAMAP-Rule:MF_02028, ECO:0000269|PubMed:15210128, ECO:0000269|Ref.9};
DE   AltName: Full=Bacteriophage N4 adsorption protein C {ECO:0000305|PubMed:8226648};
DE   AltName: Full=UDP-GlcNAc-2-epimerase {ECO:0000255|HAMAP-Rule:MF_02028, ECO:0000305};
GN   Name=wecB {ECO:0000255|HAMAP-Rule:MF_02028,
GN   ECO:0000312|EcoGene:EG11451};
GN   Synonyms=nfrC {ECO:0000303|PubMed:8226648},
GN   rffE {ECO:0000303|PubMed:2166030}, yifF;
GN   OrderedLocusNames=b3786, JW5600;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND SUBCELLULAR LOCATION.
RC   STRAIN=K12 / MC4100 / ATCC 35695 / DSM 6574;
RX   PubMed=8226648; DOI=10.1128/jb.175.21.7074-7080.1993;
RA   Kiino D.R., Licudine R., Wilt K., Yang D.H.C., Rothman-Denes L.B.;
RT   "A cytoplasmic protein, NfrC, is required for bacteriophage N4
RT   adsorption.";
RL   J. Bacteriol. 175:7074-7080(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=1379743; DOI=10.1126/science.1379743;
RA   Daniels D.L., Plunkett G. III, Burland V.D., Blattner F.R.;
RT   "Analysis of the Escherichia coli genome: DNA sequence of the region
RT   from 84.5 to 86.5 minutes.";
RL   Science 257:771-778(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   SEQUENCE REVISION TO 191.
RX   PubMed=16397293; DOI=10.1093/nar/gkj405;
RA   Riley M., Abe T., Arnaud M.B., Berlyn M.K.B., Blattner F.R.,
RA   Chaudhuri R.R., Glasner J.D., Horiuchi T., Keseler I.M., Kosuge T.,
RA   Mori H., Perna N.T., Plunkett G. III, Rudd K.E., Serres M.H.,
RA   Thomas G.H., Thomson N.R., Wishart D., Wanner B.L.;
RT   "Escherichia coli K-12: a cooperatively developed annotation snapshot
RT   -- 2005.";
RL   Nucleic Acids Res. 34:1-9(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [6]
RP   PATHWAY.
RX   PubMed=2166030;
RA   Meier-Dieter U., Starman R., Barr K., Mayer H., Rick P.D.;
RT   "Biosynthesis of enterobacterial common antigen in Escherichia coli.
RT   Biochemical characterization of Tn10 insertion mutants defective in
RT   enterobacterial common antigen synthesis.";
RL   J. Biol. Chem. 265:13490-13497(1990).
RN   [7]
RP   FUNCTION.
RC   STRAIN=O7:K1 / VW187;
RX   PubMed=7559340; DOI=10.1128/jb.177.19.5539-5546.1995;
RA   Marolda C.L., Valvano M.A.;
RT   "Genetic analysis of the dTDP-rhamnose biosynthesis region of the
RT   Escherichia coli VW187 (O7:K1) rfb gene cluster: identification of
RT   functional homologs of rfbB and rfbA in the rff cluster and correct
RT   location of the rffE gene.";
RL   J. Bacteriol. 177:5539-5546(1995).
RN   [8]
RP   FUNCTION.
RX   PubMed=8170390; DOI=10.1111/j.1365-2958.1994.tb00308.x;
RA   Macpherson D.F., Manning P.A., Morona R.;
RT   "Characterization of the dTDP-rhamnose biosynthetic genes encoded in
RT   the rfb locus of Shigella flexneri.";
RL   Mol. Microbiol. 11:281-292(1994).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, AND REACTION MECHANISM.
RX   DOI=10.1021/ja960266z;
RA   Sala R.F., Morgan P.M., Tanner M.E.;
RT   "Enzymatic formation and release of a stable glycal intermediate: the
RT   mechanism of the reaction catalyzed by UDP-N-acetylglucosamine 2-
RT   epimerase.";
RL   J. Am. Chem. Soc. 118:3033-3034(1996).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, ENZYME REGULATION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND MUTAGENESIS OF LYS-15; ASP-95; GLU-117; GLU-131 AND
RP   HIS-213.
RX   PubMed=15210128; DOI=10.1016/j.bbapap.2004.03.017;
RA   Samuel J., Tanner M.E.;
RT   "Active site mutants of the 'non-hydrolyzing' UDP-N-acetylglucosamine
RT   2-epimerase from Escherichia coli.";
RL   Biochim. Biophys. Acta 1700:85-91(2004).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEX WITH UDP, AND
RP   SUBUNIT.
RX   PubMed=11106477; DOI=10.1021/bi001627x;
RA   Campbell R.E., Mosimann S.C., Tanner M.E., Strynadka N.C.;
RT   "The structure of UDP-N-acetylglucosamine 2-epimerase reveals homology
RT   to phosphoglycosyl transferases.";
RL   Biochemistry 39:14993-15001(2000).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.31 ANGSTROMS) OF 2-376 IN COMPLEX WITH
RP   UDP-N-ACETYL-ALPHA-D-GLUCOSAMINE.
RX   PubMed=16021622; DOI=10.1002/prot.20541;
RA   Badger J., Sauder J.M., Adams J.M., Antonysamy S., Bain K.,
RA   Bergseid M.G., Buchanan S.G., Buchanan M.D., Batiyenko Y.,
RA   Christopher J.A., Emtage S., Eroshkina A., Feil I., Furlong E.B.,
RA   Gajiwala K.S., Gao X., He D., Hendle J., Huber A., Hoda K.,
RA   Kearins P., Kissinger C., Laubert B., Lewis H.A., Lin J., Loomis K.,
RA   Lorimer D., Louie G., Maletic M., Marsh C.D., Miller I., Molinari J.,
RA   Muller-Dieckmann H.J., Newman J.M., Noland B.W., Pagarigan B.,
RA   Park F., Peat T.S., Post K.W., Radojicic S., Ramos A., Romero R.,
RA   Rutter M.E., Sanderson W.E., Schwinn K.D., Tresser J., Winhoven J.,
RA   Wright T.A., Wu L., Xu J., Harris T.J.R.;
RT   "Structural analysis of a set of proteins resulting from a bacterial
RT   genomics project.";
RL   Proteins 60:787-796(2005).
CC   -!- FUNCTION: Catalyzes the reversible epimerization at C-2 of UDP-N-
CC       acetylglucosamine (UDP-GlcNAc) and thereby provides bacteria with
CC       UDP-N-acetylmannosamine (UDP-ManNAc), the activated donor of
CC       ManNAc residues. Also involved in bacteriophage N4 adsorption.
CC       {ECO:0000269|PubMed:15210128, ECO:0000269|PubMed:7559340,
CC       ECO:0000269|PubMed:8170390, ECO:0000269|PubMed:8226648,
CC       ECO:0000269|Ref.9}.
CC   -!- CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-glucosamine = UDP-N-
CC       acetyl-alpha-D-mannosamine. {ECO:0000255|HAMAP-Rule:MF_02028,
CC       ECO:0000269|PubMed:15210128, ECO:0000269|Ref.9}.
CC   -!- ENZYME REGULATION: Allosterically activated by its substrate, UDP-
CC       GlcNAc. {ECO:0000269|PubMed:15210128}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.6 mM for UDP-GlcNAc {ECO:0000269|PubMed:15210128};
CC         Note=kcat is 7.1 sec(-1). {ECO:0000269|PubMed:15210128};
CC   -!- PATHWAY: Bacterial outer membrane biogenesis; enterobacterial
CC       common antigen biosynthesis. {ECO:0000255|HAMAP-Rule:MF_02028,
CC       ECO:0000305|PubMed:2166030}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000255|HAMAP-Rule:MF_02028,
CC       ECO:0000269|PubMed:11106477}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_02028,
CC       ECO:0000269|PubMed:8226648}.
CC   -!- SIMILARITY: Belongs to the UDP-N-acetylglucosamine 2-epimerase
CC       family. {ECO:0000255|HAMAP-Rule:MF_02028, ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA67586.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L18799; AAC36847.1; -; Unassigned_DNA.
DR   EMBL; M87049; AAA67586.1; ALT_INIT; Genomic_DNA.
DR   EMBL; U00096; AAT48211.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE77512.1; -; Genomic_DNA.
DR   PIR; E65182; E65182.
DR   RefSeq; WP_001340422.1; NZ_LN832404.1.
DR   RefSeq; YP_026253.1; NC_000913.3.
DR   PDB; 1F6D; X-ray; 2.50 A; A/B/C/D=1-376.
DR   PDB; 1VGV; X-ray; 2.31 A; A/B/C/D=2-376.
DR   PDBsum; 1F6D; -.
DR   PDBsum; 1VGV; -.
DR   ProteinModelPortal; P27828; -.
DR   SMR; P27828; -.
DR   BioGrid; 4263321; 147.
DR   STRING; 511145.b3786; -.
DR   DrugBank; DB03435; Uridine-5'-Diphosphate.
DR   DrugBank; DB02196; Uridine-Diphosphate-N-Acetylgalactosamine.
DR   PaxDb; P27828; -.
DR   PRIDE; P27828; -.
DR   EnsemblBacteria; AAT48211; AAT48211; b3786.
DR   EnsemblBacteria; BAE77512; BAE77512; BAE77512.
DR   GeneID; 944789; -.
DR   KEGG; ecj:JW5600; -.
DR   KEGG; eco:b3786; -.
DR   PATRIC; 32123065; VBIEscCol129921_3902.
DR   EchoBASE; EB1420; -.
DR   EcoGene; EG11451; wecB.
DR   eggNOG; ENOG4105EAG; Bacteria.
DR   eggNOG; COG0381; LUCA.
DR   HOGENOM; HOG000076048; -.
DR   InParanoid; P27828; -.
DR   KO; K01791; -.
DR   OMA; IMKERQT; -.
DR   PhylomeDB; P27828; -.
DR   BioCyc; EcoCyc:UDPGLCNACEPIM-MONOMER; -.
DR   BioCyc; MetaCyc:UDPGLCNACEPIM-MONOMER; -.
DR   BRENDA; 3.2.1.183; 1960.
DR   BRENDA; 5.1.3.14; 2026.
DR   SABIO-RK; P27828; -.
DR   UniPathway; UPA00566; -.
DR   EvolutionaryTrace; P27828; -.
DR   PRO; PR:P27828; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0042802; F:identical protein binding; IDA:EcoCyc.
DR   GO; GO:0008761; F:UDP-N-acetylglucosamine 2-epimerase activity; IMP:EcoCyc.
DR   GO; GO:0009246; P:enterobacterial common antigen biosynthetic process; IMP:EcoCyc.
DR   CDD; cd03786; GT1_UDP-GlcNAc_2-Epimerase; 1.
DR   HAMAP; MF_02028; WecB_RffE; 1.
DR   InterPro; IPR003331; UDP_GlcNAc_Epimerase_2_dom.
DR   InterPro; IPR032892; WecB.
DR   InterPro; IPR029767; WecB-like.
DR   PANTHER; PTHR43174; PTHR43174; 1.
DR   Pfam; PF02350; Epimerase_2; 1.
DR   TIGRFAMs; TIGR00236; wecB; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Allosteric enzyme; Complete proteome; Cytoplasm;
KW   Isomerase; Reference proteome.
FT   CHAIN         1    376       UDP-N-acetylglucosamine 2-epimerase.
FT                                /FTId=PRO_0000208527.
FT   REGION      290    292       Substrate binding. {ECO:0000255|HAMAP-
FT                                Rule:MF_02028,
FT                                ECO:0000269|PubMed:11106477,
FT                                ECO:0000269|PubMed:16021622}.
FT   BINDING      10     10       Substrate. {ECO:0000255|HAMAP-
FT                                Rule:MF_02028,
FT                                ECO:0000269|PubMed:11106477,
FT                                ECO:0000269|PubMed:16021622}.
FT   BINDING      15     15       Substrate. {ECO:0000255|HAMAP-
FT                                Rule:MF_02028,
FT                                ECO:0000269|PubMed:16021622}.
FT   BINDING      95     95       Substrate. {ECO:0000255|HAMAP-
FT                                Rule:MF_02028,
FT                                ECO:0000269|PubMed:16021622}.
FT   BINDING     117    117       Substrate. {ECO:0000255|HAMAP-
FT                                Rule:MF_02028,
FT                                ECO:0000269|PubMed:16021622}.
FT   BINDING     213    213       Substrate. {ECO:0000255|HAMAP-
FT                                Rule:MF_02028,
FT                                ECO:0000269|PubMed:11106477,
FT                                ECO:0000269|PubMed:16021622}.
FT   BINDING     271    271       Substrate; via amide nitrogen and
FT                                carbonyl oxygen. {ECO:0000255|HAMAP-
FT                                Rule:MF_02028,
FT                                ECO:0000269|PubMed:11106477,
FT                                ECO:0000269|PubMed:16021622}.
FT   BINDING     276    276       Substrate. {ECO:0000255|HAMAP-
FT                                Rule:MF_02028,
FT                                ECO:0000269|PubMed:11106477,
FT                                ECO:0000269|PubMed:16021622}.
FT   BINDING     296    296       Substrate. {ECO:0000255|HAMAP-
FT                                Rule:MF_02028,
FT                                ECO:0000269|PubMed:11106477,
FT                                ECO:0000269|PubMed:16021622}.
FT   BINDING     313    313       Substrate. {ECO:0000255|HAMAP-
FT                                Rule:MF_02028,
FT                                ECO:0000269|PubMed:16021622}.
FT   MUTAGEN      15     15       K->A: More than 100-fold increase in KM
FT                                for UDP-GlcNAc.
FT                                {ECO:0000269|PubMed:15210128}.
FT   MUTAGEN      95     95       D->N: Strong decrease in activity.
FT                                {ECO:0000269|PubMed:15210128}.
FT   MUTAGEN     117    117       E->Q: Strong decrease in activity.
FT                                {ECO:0000269|PubMed:15210128}.
FT   MUTAGEN     131    131       E->Q: Strong decrease in activity.
FT                                {ECO:0000269|PubMed:15210128}.
FT   MUTAGEN     213    213       H->N: 30-fold increase in KM for UDP-
FT                                GlcNAc and 50-fold decrease in kcat.
FT                                {ECO:0000269|PubMed:15210128}.
FT   CONFLICT    191    191       Missing (in Ref. 2; AAA67586).
FT                                {ECO:0000305}.
FT   STRAND        2      7       {ECO:0000244|PDB:1VGV}.
FT   HELIX        10     25       {ECO:0000244|PDB:1VGV}.
FT   STRAND       30     35       {ECO:0000244|PDB:1VGV}.
FT   HELIX        40     43       {ECO:0000244|PDB:1VGV}.
FT   HELIX        44     49       {ECO:0000244|PDB:1VGV}.
FT   STRAND       55     57       {ECO:0000244|PDB:1VGV}.
FT   STRAND       62     65       {ECO:0000244|PDB:1F6D}.
FT   HELIX        67     85       {ECO:0000244|PDB:1VGV}.
FT   STRAND       88     93       {ECO:0000244|PDB:1VGV}.
FT   HELIX        97    107       {ECO:0000244|PDB:1VGV}.
FT   TURN        108    110       {ECO:0000244|PDB:1VGV}.
FT   STRAND      113    117       {ECO:0000244|PDB:1VGV}.
FT   HELIX       131    139       {ECO:0000244|PDB:1VGV}.
FT   STRAND      143    149       {ECO:0000244|PDB:1VGV}.
FT   HELIX       150    158       {ECO:0000244|PDB:1VGV}.
FT   HELIX       163    165       {ECO:0000244|PDB:1VGV}.
FT   STRAND      166    168       {ECO:0000244|PDB:1VGV}.
FT   HELIX       172    183       {ECO:0000244|PDB:1VGV}.
FT   TURN        184    186       {ECO:0000244|PDB:1VGV}.
FT   HELIX       188    195       {ECO:0000244|PDB:1VGV}.
FT   STRAND      205    211       {ECO:0000244|PDB:1VGV}.
FT   STRAND      215    217       {ECO:0000244|PDB:1VGV}.
FT   HELIX       220    235       {ECO:0000244|PDB:1VGV}.
FT   STRAND      239    244       {ECO:0000244|PDB:1VGV}.
FT   HELIX       249    259       {ECO:0000244|PDB:1VGV}.
FT   STRAND      265    268       {ECO:0000244|PDB:1VGV}.
FT   HELIX       273    282       {ECO:0000244|PDB:1VGV}.
FT   STRAND      284    291       {ECO:0000244|PDB:1VGV}.
FT   HELIX       293    295       {ECO:0000244|PDB:1VGV}.
FT   HELIX       297    300       {ECO:0000244|PDB:1VGV}.
FT   STRAND      304    309       {ECO:0000244|PDB:1VGV}.
FT   HELIX       314    318       {ECO:0000244|PDB:1VGV}.
FT   STRAND      321    325       {ECO:0000244|PDB:1VGV}.
FT   HELIX       329    341       {ECO:0000244|PDB:1VGV}.
FT   HELIX       343    350       {ECO:0000244|PDB:1VGV}.
FT   HELIX       361    371       {ECO:0000244|PDB:1VGV}.
SQ   SEQUENCE   376 AA;  42245 MW;  7B02EE6C2630DD77 CRC64;
     MKVLTVFGTR PEAIKMAPLV HALAKDPFFE AKVCVTAQHR EMLDQVLKLF SIVPDYDLNI
     MQPGQGLTEI TCRILEGLKP ILAEFKPDVV LVHGDTTTTL ATSLAAFYQR IPVGHVEAGL
     RTGDLYSPWP EEANRTLTGH LAMYHFSPTE TSRQNLLREN VADSRIFITG NTVIDALLWV
     RDQVMSSDKL RSELAANYPF IDPDKKMILV TGHRRESFGR GFEEICHALA DIATTHQDIQ
     IVYPVHLNPN VREPVNRILG HVKNVILIDP QEYLPFVWLM NHAWLILTDS GGIQEEAPSL
     GKPVLVMRDT TERPEAVTAG TVRLVGTDKQ RIVEEVTRLL KDENEYQAMS RAHNPYGDGQ
     ACSRILEALK NNRISL
//
